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The aim of this study was to compare the proliferative pattern of dentinogenic ghost cell tumors (DGCT) 
and unicystic calcifying cystic odontogenic tumors (UCCOT) using antibodies against PCNA, p53 and Ki-
67. Three cases diagnosed as DGCT and ten as UCCOT were retrieved from the fi les of the Surgical Oral 
Pathology Service at the University of São Paulo, Brazil. Immunohistochemistry was performed in for-
malin-fi xed and paraffi n-embedded tissue specimens. Only nuclear staining was considered specifi c for 
the three antibodies. Immunoexpression of PCNA, Ki-67 and p53 was analyzed semi-quantitatively and 
quantitatively. The results showed that PCNA was positive in both lesions, mainly in the basal cells, and 
p53 showed positivity in all cases. UCCOT showed statistically signifi cantly higher Ki-67 labeling indices 
than did DGCT. In conclusion, our results do not support the correlation between proliferative activity as 
shown by these proteins and reported biologic behavior.
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Expressão de PCNA, p53 e Ki-67 em tumor dentinogênico de células fantasmas e tumor odontogênico cístico calciﬁ cante 
unicístico • O objetivo deste estudo foi avaliar a expressão dos antígenos PCNA, p53 e Ki-67 (marcadores de proliferação), em três ca-
sos diagnosticados como tumor dentinogênico de células fantasma (TDCF) e dez casos como tumor odontogênico císticos, calcifi cante 
unicístico (TOCCU) obtidos dos arquivos do Serviço de Patologia Oral e Cirúrgica da Universidade de São Paulo, Brasil. Foram realiza-
das reações de imunohistoquímica em espécimes de tecido parafi nado. Apenas a marcação nuclear foi considerada específi ca para os 
três anticorpos. A imunoexpressão das proteínas PCNA, p53 e Ki-67 foi analisada semi-quantitativamente e quantitativamente. Os re-
sultados mostraram que o PCNA foi expresso em ambas as lesões, principalmente na camada basal, e que p53 também mostrou positiv-
idade em todos os casos. O TOCCU mostrou um aumento estatisticamente signifi cante na expressão do Ki-67 em relação ao TDCF. Em 
conclusão, nossos resultados não mostraram correlação entre a atividade proliferativa e o comportamento biológico desses tumores.
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IntroductIon
Recently, the World Health Organization 
(WHO) has made changes in the classification of 
odontogenic tumors. Calcifying odontogenic cyst 
(COC) was re-named by Prætorius and Ledesma-
Montes1 as calcifying cystic odontogenic tumor 
(CCOT) and the term dentinogenic ghost cell tu-
mor (DGCT) was maintained by the same authors.1 
Thus, CCOT was defined as a benign cystic neo-
plasm of odontogenic origin, characterized by an 
ameloblastoma-like epithelium with ghost cells 
that may calcify,1 and DGCT was defined as a lo-
cally invasive neoplasm characterized by amelo-
blastoma-like islands of epithelial cells in a mature 
connective tissue stroma. The nature of ghost cells 
has been studied by various authors with differ-
ent explanations, such as a form of abnormal kera-
tin formation, highly keratinized epithelial cells, 
true keratinization and cells which have lost their 
developmental and inductive effect.2 Cases previ-
ously called odontogenic ghost cell carcinomas and 
malignant epithelial odontogenic ghost cell tumors 
were re-named by the WHO3 as ghost cell odonto-
genic carcinomas (GCOC).
 The CCOT is an uncommon benign odontogenic 
lesion that was first described by Gorlin et al. in 
1962.4 In spite of being called cyst, there is no con-
sensus in the literature as to its classification as a 
cyst or tumor.5 Histologically, the cyst wall is lined 
by a thin ameloblastic epithelium and eosinophilic 
cells with no obvious nuclei, called “ghost cells,” 
which in turn may be calcified. In the adjacent fi-
brous area, epithelial proliferation and odontogenic 
dysplastic dentin can be observed.6
The DGCT is a rare odontogenic epithelial neo-
plasm considered the neoplastic counterpart of 
CCOT.7 Histologically, the presence of ghost cells 
within the proliferating ameloblastic epithelium 
is the essential feature for diagnosis. Varying 
amounts of dysplastic dentin are present in the sur-
rounding stroma, as well as in close contact with 
the epithelial islands or ghost cells. In addition, 
dysplastic calcifications can be found.8
The study of oncogenes and tumor suppressor 
genes such as p53, which are involved in the check-
points of cell growth, can improve understanding 
of the biological behavior of DGCT.
PCNA (proliferating cell nuclear antigen) is a 
non-histone nuclear protein required for DNA syn-
thesis and is an accessory protein for DNA poly-
merase-alpha, which is found at high levels dur-
ing the G1/S cell cycle. It is synthesized in the cell 
nucleus and has a key role in cell cycle initiation. 
PCNA is the protein most used to evaluate cell pro-
liferation immunohistochemically, since it is unde-
tectable in cells that are out of the cell cycle. The 
incidence of PCNA expression is correlated with 
mitotic activity.9,10
The Ki-67 antigen is expressed in all phases of the 
cell cycle, except G0. Its expression rises with pro-
gression of the cell cycle, increasing during the sec-
ond half of the S phase, reaching a peak in G2 and 
M and decreasing rapidly after mitosis. Thus the ex-
pression of Ki-67 reflects the number of proliferating 
cells in a tissue.11 Non-dividing or “resting” cells in 
the G0 phase are Ki-67 antigen negative.9
The p53 protein consists of a tetramer that is ac-
cumulated in the cytoplasm during the G1 phase of 
the cell cycle and migrates to the nucleus in the ear-
ly S phase, which occurs at one important check-
point in the cell’s DNA. When the DNA molecule 
has been damaged or the cell is in a stress condi-
tion, there is an overexpression of the p53 protein. 
In the nucleus, p53 acts as a transcription factor to 
activate several genes. When it is not possible to 
correct errors in the DNA molecule, p53 activates 
pathways inducing apoptosis.12
objectIve
The objective of the present study was to evalu-
ate the proliferative activity of DGCT comparing it 
to that of CCOT using PCNA, p53 and Ki-67.
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 Only nuclear staining was considered specific 
for the three antibodies. Protein expression was as-
sessed using a light microscope at a magnification 
of 40×. Protein immunoexpression of PCNA, Ki-67 
and p53 was analyzed semiquantitatively based on 
the criteria of Rahman et al. (2010)13 that consists of 
• low (score 0: negative; score +1: < 20%), 
• moderate (score +2: ≥ 20 and < 50%), and 
• high (score +3: ≥ 50%) expressions. 
For quantitative analysis, all slides were ob-
served under a light microscope and positive 
cells for anti-PCNA, anti-p53 and anti-Ki-67 were 
counted in a randomly selected field, choosing the 
most positive spots. Thus, sections were examined 
under a microscope and captured through an Axio 
Imager A2 (Zeiss Carl Zeiss Microscopy GmbH, 
Jena, Germany) with a digital camera attached 
(Zeiss - Axio Cam HRc Carl Zeiss Microscopy 
GmbH Jena, Germany) and the aid of Axio Vision 
software (Zeiss) at 400× magnification.
results
Qualitative analysis
Histologically, CCOT showed a cystic capsule 
lined by an epithelium presenting a well-defined 
basal layer of columnar cells, an overlying layer that 
usually resembled stellate reticulum and masses of 
ghost epithelial cells present in the epithelial lining 
or in the fibrous capsule. Calcified areas were pres-
ent (Figure 1A). Immunohistochemical reactions 
showed that PCNA was expressed by basal cells of 
the cystic lining epithelium. p53 showed positiv-
ity in all cases with a few positive cells. Ki-67 was 
positive in a few cells of the basal cell layer in all 
cases (Figures 1B and 1C). DGCT was represented 
histologically by the presence of large amounts of 
an amorphous eosinophilic material (dentinogen-
ic-like), interspersed by an “ameloblastoma-like” 
odontogenic epithelium and by groups of ghost cells 
(Figure 2A). As for CCOT, PCNA was expressed by 
MaterIals and Methods
Three cases diagnosed as DGCT and ten as sim-
ple, unicystic CCOT, were retrieved from the files 
of the Surgical Oral Pathology Service at the Uni-
versity of São Paulo. This manuscript has been ap-
proved by the university’s research ethics commit-
tee, number 88/11 and CAAE 0099.0.017.000-11.
Immunohistochemistry was performed in for-
malin-fixed and paraffin-embedded tissue speci-
mens. Three-µm sections were obtained, depar-
affinized in xylenes and hydrated in alcohols of 
decreasing concentration. Antigen retrieval was 
performed using a heated pH 6.0 citrate buffer (for 
PCNA), a pH 8.0 TRIS EDTA TWEEN 20 (for p53) 
or a pH 9.0 EDTA (for Ki-67). After cooling to room 
temperature, and in order to block endogenous per-
oxidase activity, sections were immersed twice for 
15 minutes in H2O2 and methanol (1/1). After rins-
ing in TRIS buffer, pH 7.6, three times, for 10 min-
utes each, the sections were incubated with prima-
ry antibodies as follows:
• PCNA (mouse monoclonal antibody, clone 
PC10, Dako, Carpinteria, CA, USA) in a dilution 
of 1:100 for 60 minutes; 
• Ki-67 (mouse monoclonal antibody, clone MIB-
1, Dako, Carpinteria, CA, USA) in a dilution of 
1:75 for 60 minutes; 
• p53 (mouse monoclonal antibody, clone DO-
7, Dako, Carpinteria, CA, USA) in a dilution of 
1:50 for 120 minutes. 
In the next stage, a biotinyl antibody was used 
in the reaction and then a streptavidin-peroxidase 
complex (LASB+ System - HRP, Dako, Carpinte-
ria, CA, USA) was applied. The antigen-antibody 
complex was visualized using DAB chromogen 
(3'3- diamonobenzidine, cat. no. S3000, Dako, Car-
pinteria, CA, USA). Positive (oral squamous cell 
carcinoma sections) and negative (omission of the 
antibody) controls were included in all the reac-
tions.
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basal cells of the odontogenic epithelium (Figure 
2B), while p53 showed positivity in all cases (Fig-
ure 2C), as did Ki-67 (Figure 2D).
Table 1 shows the score grading of DGCT for the 
immunoreactions with each antibody and Table 2 
shows the same for CCOT.
Figure 1 | Histopathology 
characteristics of CCOT showing a 
cystic lesion with a large amount of 
amorphous material and calcified 
areas (A). PCNA shows a strong 
expression in all odontogenic 
epithelium (B). p53 shows a weak 
expression with a few positive cells 
(arrows, C). Ki-67 also presents a 
weak expression, mostly in the  
basal layer of the odontogenic 
epithelium (D).
Figure 2 | Histopathology 
characteristics of DGCT showing the 
presence of ghost cells within the 
proliferating ameloblastic epithelium. 
Eosinophilic dentinoid material 
seen adjacent to the surrounding 
stroma, dysplastic calcifications and 
ghosts cells (A). PCNA is strongly 
expressed, mainly in the basal layer 
of the odontogenic epithelium (B). 
The marking of p53 appeared weak 
in all cases with the rare presence of 
positive cells (C). Ki-67 is expressed 
by a few cells of the odontogenic  
epithelium (arrows, D).
a
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statistical analysis
Exploratory data analyses were performed. The 
comparison between CCOT and DGCT was per-
formed using the nonparametric Mann-Whitney 
test.
Comparing the positive cells counted of CCOT 
and DGCT, there were no significant differ-
ences between these two types of tumors in re-
lation to PCNA (p = 0.5541) or in relation to p53 
(p = 0.0503). However, cell count was significantly 
higher for Ki-67 when comparing CCOT and DGCT 
scores (p = 0.0336).
dIscussIon
Since CCOT was characterized by Gorlin4 in 
1962 as a separate entity, the true nature of this le-
sion has been controversial in the literature, with-
out a consensus about its classification as a cyst or 
tumor.
 CCOT accounts for 1%–2% of all odontogenic 
tumors, whereas 2%–14% are classified as DGCT.14 
These lesions are characterized by a well-delineat-
ed cystic proliferation of the odontogenic epithe-
lium with ghost cells, which are degenerated epi-
thelial cells, usually calcified. It is known that this 
calcification of odontogenic epithelium is dystro-
phic. However, dentinoid or bone-like hard tissues 
have sometimes been reported to be formed in the 
cyst wall.15 The solid counterpart of CCOT is more 
aggressive and is not compatible with a cyst, tend-
ing to local recurrence after curettage.16
DGCT is an odontogenic epithelial neoplasm, 
considered the neoplastic counterpart of CCOT for 
being locally aggressive.7 DGCT often occurs as an 
intraosseous variant and less commonly as extra-
osseous. Extra-osseous lesions affect the gingivae 
and are usually asymptomatic. Their behavior is 
typically less aggressive and can be controlled by 
local excision. Intraosseous DGCT is more aggres-
sive and local resection is recommended with a 
wider margin. There is no predilection for regions 
of the maxilla and mandible; however, 75% of the 
cases affect men. The etiology remains unclear.16,17 
A few studies have been published comparing inva-
siveness and proliferation of these neoplasms. Gong 
et al. (2009)18 evaluated the nuclear expression of 
NF kappaB, MMP9 and Ki-67 in CCOT, DGCT and 
ghost cell odontogenic carcinoma. In the present 
study, no statistically significant difference in the 
expression of the proliferation markers between 
CCOT and DGCT was found, except for Ki-67 that 
was more expressed in CCOT. However, due to the 
rarity of DGCT and, consequently, the low number 
of cases analyzed, results must be examined with 
caution.
Motosugi et al. (2009)19 analyzed the hypoth-
esis of a malignant transformation from calcifying 
odontogenic cyst to ghost cell odontogenic carci-
noma (GCOC) and evaluated the expression of p53 
Table 1 | Expression of PCNA, Ki-67 and p53 in DGCT cases.
Expression of 
Ki-67
Expression of 
p53
Expression of 
PCNA
DGCT 1 +1 0 +3
DGCT 2 +1 +1 +1
DGCT 3 +1 +1 +3
Table 2 | Expression of PCNA, Ki-67 and p53 proteins in CCOT 
cases.
Expression of 
Ki-67
Expression of 
p53
Expression of 
PCNA
CCOT 1 0 +1 +2
CCOT 2 0 +1 +3
CCOT 3 +1 +1 +3
CCOT 4 +1 +1 +3
CCOT 5 +1 +1 +3
CCOT 6 +1 +1 +3
CCOT 7 +1 +2 +3
CCOT 8 +1 +2 +3
CCOT 9 0 +1 +3
CCOT 10 +1 +1 +3
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and Ki-67 in these tumors, showing that the ex-
pression of Ki-67 was also slightly positive in cases 
of GCOC, not only in cases of CCOT and DGCT.
In contrast to the present study that did not 
show any difference for the immunoexpression of 
p53 and PCNA in the studied cases, Saghafi et al. 
(2010)10 performed immunohistochemical stud-
ies of p53 antigen and PCNA in all types of CCOT, 
based on the division proposed by Prætorius in 
1981.20 A higher expression of both p53 and PCNA 
in the solid variant was observed, while the cystic 
variant had a low expression.
Non-mutated p53, a protein that monitors the 
integrity of the genome, is not detected by immu-
nohistochemical methods. Mutated or inactivated 
p53, on the contrary, can be shown in the tissues 
and could increase the pool of proliferative cells.21 
This fact may explain our results in which a few 
positive cells were present, showing that cells may 
present increased proliferation without detectable 
alterations of the p53 gene. Another interesting 
fact that could explain the decreasing proliferation 
of p53 is the methylation showed by Moreira et al. 
(2009)22 in 33.33% of CCOT. However, it is not pos-
sible to establish that epigenetic is a common event 
in these tumors.
The explanation for the high PCNA expression 
and low expression of Ki-67, both proliferation 
markers, is that PCNA expression can be correlated 
with mitotic activity,9,10 while Ki-67 decreases rap-
idly after mitosis. Therefore, we believe that the in-
creased activity of these tumors occurs soon after 
the process of mitosis.
conclusIons
In conclusion, our results show that both tumors 
had the same benign behavior and our findings do 
not support a correlation between proliferative ac-
tivity as shown by these proteins and reported bio-
logic behavior.
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